Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NCSM) 2024 Q4
NCS Multistage Holdings (NASDAQ: NCSM) reported strong financial results for Q4 2024, with total revenues increasing 28% year-over-year to $45.0 million. The growth was primarily driven by international revenue expansion in both product sales and services, particularly in Middle East tracer diagnostics projects.
Key highlights include:
- Canada achieved 19.5% year-over-year growth
- U.S. performance was mixed with product sales up 29.1% but services down 9.5%
- Consolidated gross margins improved from 36.6% in Q4 2023 to 43.1% in Q4 2024
- Liquidity position strengthened to $46.0M from $37.0M in Q3 2024
- Adjusted EBITDA reached $8.2 million, representing a $5.7 million year-over-year improvement
NCS Multistage Holdings (NASDAQ: NCSM) ha riportato risultati finanziari solidi per il quarto trimestre del 2024, con ricavi totali in aumento del 28% rispetto all'anno precedente, raggiungendo 45,0 milioni di dollari. La crescita è stata principalmente sostenuta dall'espansione dei ricavi internazionali sia nelle vendite di prodotti che nei servizi, in particolare nei progetti di diagnostica per tracciatori in Medio Oriente.
I punti salienti includono:
- Il Canada ha registrato una crescita del 19,5% rispetto all'anno precedente
- Le performance negli Stati Uniti sono state miste, con le vendite di prodotti in aumento del 29,1% ma i servizi in calo del 9,5%
- I margini lordi consolidati sono migliorati dal 36,6% nel Q4 2023 al 43,1% nel Q4 2024
- La posizione di liquidità è migliorata a 46,0 milioni di dollari rispetto ai 37,0 milioni di dollari nel Q3 2024
- Il EBITDA rettificato ha raggiunto 8,2 milioni di dollari, rappresentando un miglioramento di 5,7 milioni di dollari rispetto all'anno precedente
NCS Multistage Holdings (NASDAQ: NCSM) reportó resultados financieros sólidos para el cuarto trimestre de 2024, con ingresos totales que aumentaron un 28% interanual, alcanzando 45,0 millones de dólares. Este crecimiento fue impulsado principalmente por la expansión de ingresos internacionales tanto en ventas de productos como en servicios, especialmente en proyectos de diagnóstico de trazadores en Medio Oriente.
Los puntos destacados incluyen:
- Canadá logró un crecimiento del 19,5% interanual
- El rendimiento en EE. UU. fue mixto, con ventas de productos en aumento del 29,1% pero servicios en descenso del 9,5%
- Los márgenes brutos consolidados mejoraron del 36,6% en el Q4 2023 al 43,1% en el Q4 2024
- La posición de liquidez se fortaleció a 46,0 millones de dólares desde 37,0 millones de dólares en el Q3 2024
- El EBITDA ajustado alcanzó los 8,2 millones de dólares, lo que representa una mejora de 5,7 millones de dólares interanual
NCS 멀티스테이지 홀딩스 (NASDAQ: NCSM)는 2024년 4분기 강력한 재무 결과를 보고했으며, 총 수익이 전년 대비 28% 증가하여 4,500만 달러에 달했습니다. 이 성장은 주로 중동의 추적 진단 프로젝트에서 제품 판매 및 서비스의 국제 수익 확장에 의해 주도되었습니다.
주요 하이라이트는 다음과 같습니다:
- 캐나다는 전년 대비 19.5% 성장했습니다
- 미국의 성과는 혼조세로, 제품 판매는 29.1% 증가했지만 서비스는 9.5% 감소했습니다
- 통합 총 마진은 2023년 4분기 36.6%에서 2024년 4분기 43.1%로 개선되었습니다
- 유동성 위치는 2024년 3분기 3,700만 달러에서 4,600만 달러로 강화되었습니다
- 조정된 EBITDA는 820만 달러에 도달하여 전년 대비 570만 달러 개선되었습니다
NCS Multistage Holdings (NASDAQ: NCSM) a rapporté de solides résultats financiers pour le quatrième trimestre de 2024, avec des revenus totaux en hausse de 28 % par rapport à l'année précédente, atteignant 45,0 millions de dollars. Cette croissance a été principalement soutenue par l'expansion des revenus internationaux tant dans les ventes de produits que dans les services, en particulier dans les projets de diagnostic de traceurs au Moyen-Orient.
Les points saillants incluent :
- Le Canada a enregistré une croissance de 19,5 % par rapport à l'année précédente
- La performance aux États-Unis a été mitigée, avec des ventes de produits en hausse de 29,1 % mais des services en baisse de 9,5 %
- Les marges brutes consolidées se sont améliorées, passant de 36,6 % au T4 2023 à 43,1 % au T4 2024
- La position de liquidité s'est renforcée à 46,0 millions de dollars contre 37,0 millions de dollars au T3 2024
- Le EBITDA ajusté a atteint 8,2 millions de dollars, représentant une amélioration de 5,7 millions de dollars par rapport à l'année précédente
NCS Multistage Holdings (NASDAQ: NCSM) berichtete über starke finanzielle Ergebnisse für das 4. Quartal 2024, wobei die Gesamterlöse im Jahresvergleich um 28% auf 45,0 Millionen Dollar stiegen. Das Wachstum wurde hauptsächlich durch die Expansion der internationalen Einnahmen sowohl im Produktverkauf als auch in den Dienstleistungen vorangetrieben, insbesondere bei Projekten zur Tracerdiagnostik im Nahen Osten.
Wichtige Highlights sind:
- Kanada erzielte ein Wachstum von 19,5% im Jahresvergleich
- Die Leistung in den USA war gemischt, mit einem Anstieg der Produktverkäufe um 29,1%, während die Dienstleistungen um 9,5% zurückgingen
- Die konsolidierten Bruttomargen verbesserten sich von 36,6% im 4. Quartal 2023 auf 43,1% im 4. Quartal 2024
- Die Liquiditätsposition wurde auf 46,0 Millionen Dollar von 37,0 Millionen Dollar im 3. Quartal 2024 gestärkt
- Das bereinigte EBITDA erreichte 8,2 Millionen Dollar, was eine Verbesserung von 5,7 Millionen Dollar im Jahresvergleich darstellt
- Revenue growth of 28% Y/Y to $45.0M
- Gross margin expansion from 36.6% to 43.1%
- Liquidity position improved by $9.0M to $46.0M
- Adjusted EBITDA increased by $5.7M to $8.2M
- Strong international market performance, especially in Middle East
- Canadian market growth of 19.5% Y/Y
- U.S. services revenue declined 9.5%
- Potential impact from increasing tariffs threat
Dallas, Texas--(Newsfile Corp. - March 12, 2025) - NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners updates their coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM). In 4Q24, the Company experienced a
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Total revenues of
$45.0 million , a28% year over-year improvement. - NCSM reported a liquidity position of
$46.0M , an increase from$37.0M (3Q24). - Adjusted EBITDA of
$8.2 million , a$5.7 million year-over-year improvement.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244309
FAQ
What was NCS Multistage Holdings (NCSM) revenue growth in Q4 2024?
How did NCSM's gross margins perform in Q4 2024 compared to Q4 2023?
What was NCSM's liquidity position in Q4 2024?
How much did NCSM's Adjusted EBITDA improve year-over-year in Q4 2024?
How did NCSM perform in different geographical regions during Q4 2024?
